![](https://monteverdelaw.com/wp-content/uploads/case-logo/entasis-therapeutics-holdings-inc.png)
Entasis Therapeutics Holdings Inc. (ETTX), relating to its proposed acquisition by Innoviva, Inc. Under the terms of the agreement, ETTX shareholders will receive $2.20 in cash per share they own.
Entasis Therapeutics Holdings Inc. (ETTX), relating to its proposed acquisition by Innoviva, Inc. Under the terms of the agreement, ETTX shareholders will receive $2.20 in cash per share they own.